Tier 2 · Liquid 3000
Artiva Biotherapeutics, Inc.
ARTV · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$9.76
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001817241
Liquidity rank
#3196
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $0.00 | 2025-12-31 | 0001193125-26-100135 |
| Annual diluted EPS | -3.43 | 2025-12-31 | 0001193125-26-100135 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.95 | 2026-03-31 | 0001193125-26-213242 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.036Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-07-19 through 2026-07-19.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo FinanceYahoo Finance · 2026-07-17
Market expert healthcare poised for ‘significant upside’ earnings surprise - qz.comqz.com · 2026-07-17
Congress can finish the job on healthcare price transparency - The Washington PostThe Washington Post · 2026-07-16
Why Healthcare Stocks Look Like a Haven in This Market - Barron'sBarron's · 2026-07-16
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames